Limited data from human-based studies reveal that resveratrol improves insulin sensitivity and fasting glucose levels in patients with Type 2 Diabetes Mellitus and may improve inflammatory status in human obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.